High throughput RNAi screening identifies ID1 as a synthetic sick/lethal gene interacting with the common TP53 mutation R175H.

Abstract:

:The TP53 mutation (R175H) is one of the most common mutations in human cancer. It is a highly attractive strategy for cancer therapy to find the genes that lead the R175H-expressing cancer cells. The aim of this study was to identify the synthetic sick/lethal gene interacting with R175H. Using lentiviral bar-coded comprehensive shRNA library and a tetracycline-inducible R175H expressed in the SF126 human glioblastoma cell line (SF126-tet-R175H), we conducted high-throughput screening to identify the candidate genes that induce synthetic sickness/lethality in R175H-expressing cells. We identified 906 candidate gene suppressions that may lead to accelerated cell growth inhibition in the presence of R175H. Inhibitor of differentiation 1 (ID1) was one of the candidate genes, and its suppression by siRNA resulted in the acceleration of growth inhibition in cell lines both transiently and endogenously expressing R175H but not in TP53-null cell lines or other common p53 mutants (such as R273H). Flow cytometry analysis showed that ID1 suppression resulted in G1 arrest, and the arrest was accelerated by the expression of R175H. ID1 is a synthetic sick/lethal gene that interacts with R175H and is considered to be a novel molecular target for cancer therapy in R175H-expressing cells.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Imai H,Kato S,Sakamoto Y,Kakudo Y,Shimodaira H,Ishioka C

doi

10.3892/or.2013.2953

subject

Has Abstract

pub_date

2014-03-01 00:00:00

pages

1043-50

issue

3

eissn

1021-335X

issn

1791-2431

journal_volume

31

pub_type

杂志文章
  • Impact of RNA‑binding motif 3 expression on the whole transcriptome of prostate cancer cells: An RNA sequencing study.

    abstract::RNA‑binding motif 3 (RBM3) is a cold‑shock protein that has been previously shown to attenuate cancer stem cell‑like features in prostate cancer (PCa) cells. However, the mechanism underlying RBM3 regulation in PCa cells is largely unknown. The present study investigated the impact of RBM3 expression on the whole tran...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6618

    authors: Dong Q,Lv C,Zhang G,Yu Z,Kong C,Fu C,Zeng Y

    更新日期:2018-10-01 00:00:00

  • Interference of STAT 5b expression enhances the chemo-sensitivity of gastric cancer cells to gefitinib by promoting mitochondrial pathway-mediated cell apoptosis.

    abstract::Signal transducer and activator of transcription (STAT) 5, including STAT 5a and STAT 5b, was reported to play important roles in the malignant biological behaviors of tumors. However, their roles in gastric cancer, especially for STAT 5b remain unknown. This study aimed to detect the expression of STAT 5b in gastric ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.3994

    authors: Sun T,Jia Y,Xiao D

    更新日期:2015-07-01 00:00:00

  • MicroRNA-302a enhances 5-fluorouracil-induced cell death in human colon cancer cells.

    abstract::New therapeutic strategies are needed for colorectal cancer (CRC) treatment. MicroRNAs are involved in cancer‑pertinent cellular processes, including chemoresistance. As miR‑302a is an embryonic stem cell‑specific microRNA, studies on miR‑302a have focused on its role in human stem cells. Studies analyzing miR‑302 fun...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5237

    authors: Liu N,Li J,Zhao Z,Han J,Jiang T,Chen Y,Hou N,Huang C

    更新日期:2017-01-01 00:00:00

  • A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate cancer.

    abstract::Insulin-like growth factor (IGF)-mediated signaling is a newly recognized clinical target in prostate cancer, and it is hypothesized that blockade of the IGF receptor (IGF1R) will impair downstream signaling and slow tumor growth. In this study the efficacy of nordihydroguaiaretic a...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1487

    authors: Friedlander TW,Weinberg VK,Huang Y,Mi JT,Formaker CG,Small EJ,Harzstark AL,Lin AM,Fong L,Ryan CJ

    更新日期:2012-01-01 00:00:00

  • Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5076 bearing mice.

    abstract::The present study was designed to investigate the effects of Bowman-Birk inhibitor (BBI) on up-regulation of connexin (Cx) expression to estimate BBI's tumor-suppressor effect in mice with M5076 ovarian sarcoma. The relative tumor weight (p<0.05, r(2)=0.301) and proliferating cell nuclear antigen (PCNA, p<0.01, r(2)=0...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Suzuki K,Yano T,Sadzuka Y,Sugiyama T,Seki T,Asano R

    更新日期:2005-06-01 00:00:00

  • Gut-derived serotonin induced by depression promotes breast cancer bone metastasis through the RUNX2/PTHrP/RANKL pathway in mice.

    abstract::Breast cancer metastasizes to the bone in a majority of patients with advanced disease resulting in bone destruction. The underlying mechanisms are complex, and both processes are controlled by an interaction between locally and systemically derived signals. Clinically, breast cancer patients with depression have a hi...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4430

    authors: Zong JC,Wang X,Zhou X,Wang C,Chen L,Yin LJ,He BC,Deng ZL

    更新日期:2016-02-01 00:00:00

  • Critical role of aquaporin-3 in epidermal growth factor-induced migration of colorectal carcinoma cells and its clinical significance.

    abstract::Aquaporins (AQPs) are a family of small, integral membrane proteins that have been shown to play an important role in tumor development and metastasis. Several studies have demonstrated that expression of AQP3 contributes to the enhanced migration of epithelial cells and is related to differentiation, metastasis and v...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2144

    authors: Li A,Lu D,Zhang Y,Li J,Fang Y,Li F,Sun J

    更新日期:2013-02-01 00:00:00

  • Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer.

    abstract::Cancer represents a significant challenge for humankind, as early diagnosis and treatment are difficult to achieve. To systemically investigate the effect of sex, body mass index (BMI) and age on cancer incidence and prognosis, the data from 14,504 cases of cancer were downloaded from The Cancer Genome Atlas (TCGA). B...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6529

    authors: Huang X,Shu C,Chen L,Yao B

    更新日期:2018-09-01 00:00:00

  • Expression of DNA double-strand break repair proteins predicts the response and prognosis of colorectal cancer patients undergoing oxaliplatin-based chemotherapy.

    abstract::DNA intrastrand cross-linking agents such as oxaliplatin induce DNA double-strand breaks (DSBs) during DNA repair and replication. In the present study, we hypothesized that DNA intrastrand cross-linking agents may significantly benefit colorectal cancer patients with deficiencies in DSB repair. Seventy-eight patients...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4488

    authors: Ihara K,Yamaguchi S,Ueno N,Tani Y,Shida Y,Ogata H,Domeki Y,Okamoto K,Nakajima M,Sasaki K,Tsuchioka T,Mitomi H,Kato H

    更新日期:2016-03-01 00:00:00

  • Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast.

    abstract::Despite intense research in the field of breast cancer it still remains the most common cancer in women in the Western world. A decreasing trend in mortality was mainly achieved by improved early detection which led to an increased incidence of ductal carcinoma in situ (DCIS) of the breast. For the patient's prognosis...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Schmid BC,Rudas M,Fabjani G,Speiser P,Kaserer K,Leodolter S,Zeillinger R

    更新日期:2003-11-01 00:00:00

  • Association of annexin A2 with cancer development (Review).

    abstract::Annexin A2 (ANXA2) is a well-known calcium-dependent phospholipid binding protein widely distributed in the nucleus, cytoplasm and extracellular surface of various eukaryotic cells. It has been recognized as a pleiotropic protein affecting a wide range of molecular and cellular processes. Dysregulation and abnormal ex...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or.2015.3837

    authors: Xu XH,Pan W,Kang LH,Feng H,Song YQ

    更新日期:2015-05-01 00:00:00

  • Do Ki67, S-phase, S + G2M and DNA ploidy, evaluated by flow cytometry, reveal locoregional metastasis in oral cavity and oropharynx carcinomas?

    abstract::Tumour cell proliferation is an important biological prognostic parameter to be considered alongside clinical and histopathological parameters. It has been evaluated by immunohistochemistry using proliferative markers (PCNA, Ki67, etc.) and by flow cytometry considering DNA content, growth fraction (S + G2M) and S-pha...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Tirelli G,Sidari L,Giacomarra V,Papanikolla L,Sasso F,Russolo M,Melato M

    更新日期:2002-05-01 00:00:00

  • Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.

    abstract::Survivin, an anti-apoptotic protein, is abundantly expressed in a variety of cancer cells, including hepatoma cells, resulting in the resistance of these cells to various apoptotic stimuli. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is known to induce cancer cell-specific apoptosis, but hepa...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Nakao K,Hamasaki K,Ichikawa T,Arima K,Eguchi K,Ishii N

    更新日期:2006-08-01 00:00:00

  • Telomerase activity in gynecological tumors.

    abstract::The aim of this study was to define the clinical implications of semi-quantitative telomerase activity in gynecological tumors by comparing the telomerase activity of cancerous lesion and the adjacent non-cancerous lesion. In 118 cases of gynecologic tumors, including 41 uterine cervical tumors, 43 uterine body tumors...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.7.5.1003

    authors: Sakamoto M,Toyoizumi T,Kikuchi Y,Okamoto A,Nakayama H,Aoki D,Yamamoto K,Hata H,Sugishita T,Tenjin Y

    更新日期:2000-09-01 00:00:00

  • Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication.

    abstract::TRIM58 (tripartite motif containing 58) has been reported as a novel methylated gene in hepatocellular carcinoma (HCC) by methylation microarrays. However, its associations with mRNA expression and clinicopathological characteristics have not been evaluated. In this study, we explored the potential clinical implicatio...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4871

    authors: Qiu X,Huang Y,Zhou Y,Zheng F

    更新日期:2016-08-01 00:00:00

  • Differentially expressed microRNAs in exosomes of patients with breast cancer revealed by next‑generation sequencing.

    abstract::MicroRNAs (miRNAs/miRs) in exosomes play crucial roles in the onset, progression and metastasis of cancer by regulating the stability of target mRNAs or by inhibiting translation. In the present study, differentially expressed miRNAs were identified in exosomes of 27 breast cancer patients and 3 healthy controls using...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7401

    authors: Wu H,Wang Q,Zhong H,Li L,Zhang Q,Huang Q,Yu Z

    更新日期:2020-01-01 00:00:00

  • Male breast cancer: risk factors, diagnosis, and management (Review).

    abstract::Male breast cancer (MBC) is extremely rare, with an incidence in the general US population of <1%. It tends to be diagnosed at later stages than breast cancer in females, likely because of low awareness on the part of the patient and low suspicion by the physician. Risk factors include genetic predisposition, alterati...

    journal_title:Oncology reports

    pub_type: 杂志文章,评审

    doi:10.3892/or_00000962

    authors: Johansen Taber KA,Morisy LR,Osbahr AJ 3rd,Dickinson BD

    更新日期:2010-11-01 00:00:00

  • Treatment with HER-2 phosphorylation agonists enhance tumor ability to stimulate epitope specific CTL in vitro.

    abstract::The transmembrane (TM) receptor encoded by the HER-2 proto-oncogene (HER-2) is amplified in several types of human carcinomas and premalignant states and provides an important target for cancer therapy. While overexpression of HER-2 should lead to increased CTL epitope formation due to the attendant increase in higher...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Castilleja A,Ward NE,Epstein RB,Kudelka AP,Gershenson DM,Efferson CL,O'Brian CA,Ioannides CG

    更新日期:2002-09-01 00:00:00

  • Casticin induces growth suppression and cell cycle arrest through activation of FOXO3a in hepatocellular carcinoma.

    abstract::Casticin, a polymethoxyflavone, has been reported to exert anticancer activities. The objectives of this study were to examine the molecular mechanisms by which casticin induces the growth inhibition and cell cycle arrest in human hepatocellular carcinoma (HCC) cells. The HCC cell l...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2076

    authors: He L,Yang X,Cao X,Liu F,Quan M,Cao J

    更新日期:2013-01-01 00:00:00

  • Upregulation of UHRF1 promotes the progression of melanoma by inducing cell proliferation.

    abstract::Melanoma is the most aggressive cutaneous cancer due to its propensity to metastasise and proliferate. Melanoma accounts for 80‑90% of skin‑cancer related deaths worldwide. Alhough numerous published studies have attempted to define the markers of diagnosis and prognosis of melanoma, a sensitive and specific biomarker...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6356

    authors: Wei C,Lu N,Wang L,Zhang Y,Feng Z,Yang Y,Qi F,Gu J

    更新日期:2018-06-01 00:00:00

  • Identification and characterization of sexual dimorphism‑linked gene expression profile in hepatocellular carcinoma.

    abstract::Hepatocellular carcinoma (HCC) is sexually disparate in humans, with a significantly increased prevalence in males. The molecular mechanisms by which the inhibition or development of liver cancer are facilitated require further investigation with regard to sex factors affecting disease progression. In the present stud...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7217

    authors: Wu Y,Yao N,Feng Y,Tian Z,Yang Y,Zhao Y

    更新日期:2019-09-01 00:00:00

  • Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.

    abstract::Clear cell renal cell carcinoma (ccRCC) is the main subtype of malignant kidney cancer. Long non‑coding RNA (lncRNA) serves a key role in predicting survival in patients with cancer. The present study aimed to develop an lncRNA‑related signature of prognostic values for patients with ccRCC. RNA sequencing data of 454 ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6540

    authors: Liu T,Sui J,Zhang Y,Zhang XM,Wu WJ,Yang S,Xu SY,Hong WW,Peng H,Yin LH,Pu YP,Liang GY

    更新日期:2018-09-01 00:00:00

  • Serum levels of β-catenin as a potential marker for genotype 4/hepatitis C-associated hepatocellular carcinoma.

    abstract::The global rising incidence of hepatocellular carcinoma (HCC), which parallels the increase of hepatitis C virus (HCV) prevalence, has sparked a renewed interest in discovering additional HCC serum markers. In this study, we investigated the clinical use of serum E-cadherin, ICAM, MMP-2, VEGF, OPN and β-catenin as pot...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1355

    authors: Zekri AR,Bahnassy AA,Alam El-Din HM,Morsy HM,Shaarawy S,Moharram NZ,Daoud SS

    更新日期:2011-10-01 00:00:00

  • NF-YA promotes invasion and angiogenesis by upregulating EZH2-STAT3 signaling in human melanoma cells.

    abstract::The process of angiogenesis is essential for tumor development and metastasis. Vascular endothelial growth factor (VEGF), which is overexpressed in most human cancers, has been demonstrated to be a major modulator of angiogenesis. Thus, inhibition of VEGF signaling has the potential for tumor anti-angiogenic therapy. ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4761

    authors: Xu Z,Sun Y,Guo Y,Qin G,Mu S,Fan R,Wang B,Gao W,Wu H,Wang G,Zhang Z

    更新日期:2016-06-01 00:00:00

  • Suppression of Elk1 inhibits thyroid cancer progression by mediating PTEN expression.

    abstract::ETS‑domain containing protein (Elk1) is reported to be a member of the ETS oncogene family, and promotes tumorigenesis in cancer such as bladder, prostate and ovarian. Nevertheless, the role of Elk1 in thyroid cancer progression remains unclear. In the present study, we aimed to investigate the role and underlying mol...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6554

    authors: Kong Y,Yin J,Fu Y,Chen Y,Zhou Y,Geng X

    更新日期:2018-09-01 00:00:00

  • Loss of mitochondrial DNA enhances angiogenic and invasive potential of hepatoma cells.

    abstract::Mitochondrial DNA (mtDNA) mutations are frequently found in a variety of tumors. However, the role of mtDNA mutations in tumor behavior is poorly understood. We explored the effects of mtDNA mutations on tumor phenotype employing mtDNA-depleted SK-Hep1 rho0 hepatoma cells. Expression of hypoxia inducible factor (HIF)-...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Cheon H,Moon HE,Lee MS,Kim SS

    更新日期:2010-03-01 00:00:00

  • Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells.

    abstract::Increasing evidence suggests that microRNAs are involved in human carcinogenesis as tumor suppressors or oncogenes. A growing number of reports has shown that an interest has been sparked in aberrant microRNA expression and how they can be used to treat human diseases, including cancer. However, their precise biologic...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000834

    authors: Pan J,Hu H,Zhou Z,Sun L,Peng L,Yu L,Sun L,Liu J,Yang Z,Ran Y

    更新日期:2010-07-01 00:00:00

  • Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine.

    abstract::Prostate cancer is a leading cause of cancer-related death among men. Early diagnosis and treatment are successful against prostate cancer, yet the clinical treatment of advanced prostate cancer remains a challenge. Gemcitabine is used to treat a broad spectrum of solid tumors; however, the clinical response of prosta...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3696

    authors: Guo Z,Zhang X,Li X,Xie F,Su B,Zhang M,Zhou L

    更新日期:2015-03-01 00:00:00

  • Thymidylate synthase expression levels: a prognostic and predictive role in advanced colorectal cancer.

    abstract::Thymidylate synthase (TS) is the rate-limiting enzyme in the synthesis of pyrimidine nucleotides, required for DNA synthesis, and is also a critical target for fluoropyrimidines, which are widely used in the treatment of gastrointestinal tumours. We examined TS expression in tumours from 86 patients with advanced colo...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.14.3.657

    authors: Bendardaf R,Lamlum H,Elzagheid A,Ristamäki R,Pyrhönen S

    更新日期:2005-09-01 00:00:00

  • Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk.

    abstract::Previous studies have suggested that certain genetic polymorphisms, specifically the Xeroderma pigmentosum group D (XPD) gene codon 751 and the X-ray repair cross-complementing group 1 (XRCC1) gene codon 399 polymorphisms, were associated with an increased risk of lung cancer, and, in some studies, with a greater risk...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000854

    authors: Gao W,Romkes M,Zhong S,Nukui T,Persad RA,Smith PJ,Branch R,Keohavong P

    更新日期:2010-07-01 00:00:00